Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)
Clinical trial NCT05630820 · COMPLETED
Trial details
- NCT number
- NCT05630820
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2025-11-03
- Enrollment
- 857
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.